Literature DB >> 26118413

Cytokines as biomarkers of Crimean-Congo hemorrhagic fever.

Anna Papa1, Katerina Tsergouli1, Dilek Yağcı Çağlayık2, Silvia Bino3, Najada Como4, Yavuz Uyar5, Gulay Korukluoglu2.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a potentially severe disease caused by CCHF virus. As in other viral hemorrhagic fevers, it is considered that the course and outcome of the disease depend on the viral load and the balance among the immune response mediators, and that a fatal outcome is the result of a "cytokine storm." The level of 27 cytokines was measured in serum samples taken from 29 patients during the acute phase of the disease. Two cases were fatal. Among survivors, significant differences between severe and non-severe cases were observed in the levels of IP-10, and MCP-1, while the levels of IL-1b, IL-5, IL-6, IL-8, IL-9, IL-10, IL-15, IP-10, MCP-1, TNF-α, and RANTES differed significantly between fatal and non-fatal cases (P < 0.05). RANTES was negatively correlated with the outcome of the disease. A striking similarity with the cytokine patterns seen in Ebola virus disease was observed. A weak Th1 immune response was seen. The viral load was positively correlated with IL-10, IP-10, and MCP-1 levels, and negatively correlated with the ratio IL-12/IL-10. Especially IP-10 and MCP-1 were significantly associated with the viral load, the severity and outcome of the disease, and they could act as biomarkers and, probably, as potential targets for treatment strategies design.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Crimean-Congo hemorrhagic fever; biomarkers; chemokines; cytokines

Mesh:

Substances:

Year:  2015        PMID: 26118413     DOI: 10.1002/jmv.24312

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  24 in total

1.  Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.

Authors:  David W Hawman; Kimberly Meade-White; Elaine Haddock; Rumi Habib; Dana Scott; Tina Thomas; Rebecca Rosenke; Heinz Feldmann
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

2.  Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.

Authors:  Marko Zivcec; Lisa I W Guerrero; César G Albariño; Éric Bergeron; Stuart T Nichol; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2017-08-24       Impact factor: 5.970

3.  The Non-structural Protein NSs of SFTSV Causes Cytokine Storm Through the Hyper-activation of NF-κB.

Authors:  Jumana Khalil; Shintaro Yamada; Yuta Tsukamoto; Hiroto Abe; Masayuki Shimojima; Hiroki Kato; Takashi Fujita
Journal:  Mol Cell Biol       Date:  2020-12-07       Impact factor: 4.272

Review 4.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

5.  Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.

Authors:  Elizabeth R Wonderlich; Amy L Caroline; Cynthia M McMillen; Aaron W Walters; Douglas S Reed; Simon M Barratt-Boyes; Amy L Hartman
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

6.  A cynomolgus macaque model for Crimean-Congo haemorrhagic fever.

Authors:  Elaine Haddock; Friederike Feldmann; David W Hawman; Marko Zivcec; Patrick W Hanley; Greg Saturday; Dana P Scott; Tina Thomas; Miša Korva; Tatjana Avšič-Županc; David Safronetz; Heinz Feldmann
Journal:  Nat Microbiol       Date:  2018-04-09       Impact factor: 17.745

7.  Apoptosis-Related Gene Expression in an Adult Cohort with Crimean-Congo Hemorrhagic Fever.

Authors:  Nil Guler; Cafer Eroglu; Hava Yilmaz; Adil Karadag; Hasan Alacam; Mustafa Sunbul; Tom E Fletcher; Hakan Leblebicioglu
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

Review 8.  Development of vaccines against Crimean-Congo haemorrhagic fever virus.

Authors:  Stuart D Dowall; Miles W Carroll; Roger Hewson
Journal:  Vaccine       Date:  2017-07-04       Impact factor: 3.641

Review 9.  Crimean-Congo Hemorrhagic Fever: Tick-Host-Virus Interactions.

Authors:  Anna Papa; Katerina Tsergouli; Katerina Tsioka; Ali Mirazimi
Journal:  Front Cell Infect Microbiol       Date:  2017-05-26       Impact factor: 5.293

10.  Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys.

Authors:  Robert W Cross; Abhishek N Prasad; Viktoriya Borisevich; Joan B Geisbert; Krystle N Agans; Daniel J Deer; Karla A Fenton; Thomas W Geisbert
Journal:  PLoS Negl Trop Dis       Date:  2020-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.